Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Walgreens Boots Alliance, Inc. - Common Stock (NQ:WBA)

11.49 +0.01 (+0.09%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Walgreens Boots Alliance, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
3 Reasons to Sell WBA and 1 Stock to Buy Instead
In a sliding market, Walgreens has defied the odds, trading up to $11.26 per share. Its 25.4% gain since December 2024 has outpaced the S&P 500’s 2.4% drop. This was partly due to its solid quarterly... 
Via StockStory
Topics Stocks Supply Chain
Can I Rely on Dividends for Life After Quitting My Job?
Via The Motley Fool
Motley Fool Co-Founder David Gardner: What Rule Breakers Value
If you want to own best-in-class companies, you need to own stocks with a high sticker price. 
Via The Motley Fool
3 Brilliant Stocks to Buy With $200 and Hold for 5 Years
Via The Motley Fool
Topics Artificial Intelligence World Trade
Preventing Shingles: A Local Pharmacist on the Importance of Getting Vaccinated
Via Brandpoint
3 Unprofitable Stocks with Mounting Challenges
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. 
Via StockStory
3 Value Stocks in the Doghouse
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are... 
Via StockStory
Warren Buffett Revealed a Previously Undisclosed Secret to How He Beats Wall Street. Here's How It Can Help You Make Money, Too.
Via The Motley Fool
Novo Nordisk CEO Lars Jørgensen Steps Down Amid Challenges, Retail Chatter Spikes
The company said it would announce the next CEO in “due course,” but did not provide a more definite timeline. 
Via Stocktwits
CVS, Walgreens To Buy Pharmacy Assets From Rite Aid Corp: Retail Sentiment Brightens
The U.S. Bankruptcy Court for the District of New Jersey must approve the transactions, and it is currently scheduled to conduct a hearing to approve the sales on May 21, 2025. 
Via Stocktwits
Topics Bankruptcy
Walgreens To Expand Use Of Prescription-Filling Robots, Cites $500 Million In Savings As Motive
Via Benzinga
2 Palantir Tales: The Business and the Stock
We've also got some tips for dodging AI-fueled scams. 
Via The Motley Fool
Topics Artificial Intelligence
Realty Income Stock Could Soar 20%, According to a Wall Street Analyst. Is It a Buy Now?
Via The Motley Fool
Want $1,000 in Annual Dividends? Invest $18,000 in This Tariff-Resistant Dividend Powerhouse
Via The Motley Fool
Topics World Trade
1 Ultra-High-Yield Dividend Stock to Buy Like There's No Tomorrow During the Tariff Tizzy
With uncertainty around tariffs still lingering, investors may want to add some reliable dividend income to their portfolio. 
Via The Motley Fool
Topics Economy Government World Trade
Leslie's (LESL) To Report Earnings Tomorrow: Here Is What To Expect
Pool products retailer Leslie’s (NASDAQ:LESL) will be announcing earnings results tomorrow afternoon. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
PLTR Q1 Earnings Call: AI-Driven U.S. Growth Lifts Palantir’s Outlook Amid International Headwinds
Data-mining and analytics company Palantir (NYSE:PLTR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 39.3% year on year to $883.9 million. The company expects next quarter’s... 
Via StockStory
Topics Artificial Intelligence Earnings
5 Reasons to Buy Realty Income Stock Like There's No Tomorrow
The retail REIT is still a reliable investment in an unpredictable market. 
Via The Motley Fool
Topics Bonds Economy Government
What To Expect From National Vision’s (EYE) Q1 Earnings
Optical retailer National Vision (NYSE:EYE) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
3 S&P 500 Stocks in the Doghouse
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks
3 Small-Cap Stocks in the Doghouse
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Topics Economy
Peering Into Walgreens Boots Alliance's Recent Short Interest
Via Benzinga
Want $1,000 Per Year in Reliable Dividend Income? Invest $17,300 in These 2 High-Yield Dividend Stocks
Via The Motley Fool
Topics Retirement
2 Millionaire-Maker Technology Stocks
Via The Motley Fool
5 Monster Stocks -- Such as Ford -- to Hold for the Next 10 Years
Via The Motley Fool
Topics Economy
Tractor Supply (TSCO) To Report Earnings Tomorrow: Here Is What To Expect
Rural goods retailer Tractor Supply (NASDAQ:TSCO) will be reporting results tomorrow before the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Uber Stock Slips After FTC Files Lawsuit Over 'Deceptive' Subscription Practices: Retail's Divided
The FTC alleged in a lawsuit that the ride-hailing firm charged consumers for its Uber One subscription service without their consent. 
Via Stocktwits
Topics Lawsuit
Walgreens To Pay $300M For Illegally Filling Unlawful Opioid Prescriptions, Submitting False Claims To Federal Government
Federal prosecutors alleged that Walgreens violated the Controlled Substances Act by repeatedly filling prescriptions flagged as potentially unlawful. 
Via Stocktwits
Topics Artificial Intelligence
Walgreens Must Pay $300 Million In Opioid Case, Additional $50 Million If Sold Or Merged Before 2032
Walgreens settles with U.S. government for $300 million over allegations it filled unlawful opioid prescriptions. 
Via Benzinga
MarketBeat Week in Review – 04/14 - 04/18
Stocks were down in a shortened trading week, and tariffs will continue to take center stage as several key companies report earnings 
Via MarketBeat
Topics Artificial Intelligence Economy Electric Vehicles
< Previous 1 2 3 4 5 6 7 8 9
...
61 62 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.